Stockhub

Editing Optiscan Imaging Limited

Revision as of 21:51, 9 August 2022 by >Paris (Created page with "Optiscan Imaging Limited develops and commercializes confocal endomicroscopes for clinical and pre-clinical applications in Australia, the United States, China, and Germany. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes designed for translational and pre-clinical research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered i...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see Stockhub:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)
Retrieved from "https://stockhub.co/research/Optiscan_Imaging_Limited"